Paper Details

  1. Home
  2. Paper Details

Ustekinumab associated chronic eosinophilic pneumonia.

Author: ChizingaMwelwa, KalraSaminder Singh, PapierniakEric S, Trillo-AlvarezCesar

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Ustekinumab, a drug used to treat psoriasis and other autoimmune diseases, can cause a rare but serious side effect called eosinophilic pneumonia. This case report describes a patient who developed eosinophilic pneumonia after starting ustekinumab. The patient's symptoms resolved after stopping ustekinumab and receiving treatment with prednisone.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: Ustekinumab-induced eosinophilic pneumonia is rare and to our knowledge, this is the fifth reported case of such an entity. CASE STUDY: A 60-year-old female was admitted with worsening shortness of breath and a nonproductive cough for 4 months. Her past medical history was significant...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/02770903.2020.1827416

データ提供：米国国立医学図書館（NLM）

Ustekinumab and Eosinophilic Pneumonia: A Case of Drug-Induced Lung Disease

The field of medicine is constantly evolving, with new drugs and treatment approaches emerging. This study presents a rare case of ustekinumab-induced eosinophilic pneumonia, highlighting the potential for drug-induced lung diseases to develop even with seemingly safe medications.

Understanding the Risks: Drug-Induced Lung Disease

The study highlights the importance of recognizing drug-induced lung diseases, as they may not always have a strong temporal association with symptom onset. The case presented underscores the need for careful monitoring of patients receiving ustekinumab and other medications, especially those with a history of lung disorders.

The Need for Vigilance in Drug-Induced Lung Disease

This case underscores the importance of recognizing and treating drug-induced lung diseases. It emphasizes the need for a thorough evaluation and timely diagnosis, ensuring optimal treatment and management of these potentially serious conditions.

Dr. Camel's Conclusion

This case study reminds us of the potential for unexpected and rare adverse effects from medications. It highlights the need for vigilance in recognizing and managing drug-induced lung diseases, ensuring patient safety and appropriate treatment.

Date :
  1. Date Completed 2021-12-20
  2. Date Revised 2021-12-20
Further Info :

Pubmed ID

32962463

DOI: Digital Object Identifier

10.1080/02770903.2020.1827416

Related Literature

Article Analysis
・Causes of psoriatic arthritis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.